POX

Enzyme Immunoassay, Oxcarbazepine Metabolite

Product code
POX
Device name
Enzyme Immunoassay, Oxcarbazepine Metabolite
Device class
Class 2
21 CFR
21 CFR 862.3645
Medical specialty
Clinical Toxicology
Marketing pathway
510(K)
Flag
Third-party review eligible
510(k) clearances (all years, FDA)
1 (all years; only the last 3 years are listed here)

FDA classification definition

An Oxcarbazepine Metabolite Assay is an enzyme immunoassay intended for the quantitative determination of Oxcarbazepine Metabolite in human serum. The measurements obtained are used in monitoring levels of Oxcarbazepine Metabolite to help ensure appropriate therapy.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

Official FDA classification page: POX
Classification and pathway per current FDA publications. Data from openFDA (CC0).